Table of Contents
Emami Limited stock performance
Emami’s stock has corrected by approximately 3.5% since reaching its 52-week high of Rs.546.25. It closed at Rs.521.90 on the BSE. After underperforming the Nifty FMCG index for some time, Emami’s stock has surged over 13% in the past month and has been on an uptrend since March, gaining about 54% during this period.
Emami Limited growth drivers
- Pain management grew by 13% YoY.
- Healthcare grew by 11%.
- Antiseptic cream BoroPlus grew by 19%.
- These channels, accounting for about 10% of sales, posted impressive growth of 45% and 47% respectively in the first quarter.
- They contributed significantly to revenues, with a 510 basis points (bps) YoY increase.
- Reduction in promoter share pledge. Emami Limited plans to reduce their share pledge from 33% to 18% following the sale of the promoter group hospital (AMRI Hospitals).
Emami Limited Future outlook
- Emami expects growth in modern trade and e-commerce to continue, targeting 15-20% growth.
- For FY24, the company anticipates revenue growth of 8-10% with an operating profit margin expansion of 200-250 bps.
- International business, male grooming, and healthcare segments are expected to drive growth.
Emami Limited Stock details
For the last 3 years, Company sales and profits have recorded CAGR growth of 9% and 28% respectively. Market Cap of the company as on today is about Rs.23,421 Cr.
The company is almost debt free. It also maintains very good ROCE & ROE of 28.1% and 28.3% respectively.
Emami About
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.
Financial reports and details can be accessed from company website here
Also read: Have a look at the following story.
Disclaimer:
This is not a stock recommendation. All efforts have been made to correctly represent facts and figures in the post. Investors must therefore exercise due caution while investing or trading in stocks. NSE Options.in or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
